🇪🇺 must ensure discoveries made here are developed, manufactured & scaled here. We are acting to turn health innovation into real benefits for patients - it means supporting manufacturing, biotech & secure medicine supply while keeping prevention, safety & quality at the centre. #HealthInnovation #Biotech #Manufacturing #EU
My exchange with @Google Chief Health Officer @mdhowellmd gave good insight into how #AI can transform public health, shorten the translation of scientific discoveries to make society more aware of health risks at personal level as well as support health professionals. https://t.co/HRNzKo6drA #AI #PublicHealth #HealthInnovation #Nospecificcountrycodesarementionedinthetweet.
The next step is personalised prediction. With AI, digital tools and health data, we can identify cardiovascular risks earlier and support more targeted prevention. This is why the #EHDS, #SafeHeartsPlan and innovation-friendly rules must work together. #PersonalisedPrediction #CardiovascularHealth #HealthInnovation #Nospecificcountrycodescanbeidentifiedfromthetweet.
This is where data, AI, diagnostics & medical devices can deliver practical results. With the #SafeHeartsPlan, #BiotechAct, medical devices reform & the European Health Data Space, 🇪🇺 is putting prevention and innovation at the centre. Aim: act earlier, detect sooner, save lives. #HealthInnovation #MedicalDevices #DataDrivenHealthcare #EU
This week's episode of viroLOGICAL focuses on HIV therapeutics and vaccines and how a deadly infection was transformed into a managable health condition through science and innovation. ➡️ Spotify: https://t.co/ijZFk6dhCN ➡️ Apple Podcasts: https://t.co/L2q2NtbKdr #HIV #HealthInnovation #Podcast #Nospecificcountriesarementionedinthetweet.Therefore #therearenocountrycodestoreturn.
This week I met with @moderna_tx CEO Stéphane Bancel to exchange on the future of health innovation. We discussed how 🇪🇺 can strengthen its biotech ecosystem, support vaccine & medicines development and how to maximise the role of vaccines in disease prevention. https://t.co/JMCwmg5YD0 #HealthInnovation #Biotech #Vaccines #EU
helping national authorities take decisions on which new treatments to make available to patients. Robust, high-quality&uniform data can accelerate pricing&reimbursement decisions. Now with Member States we must use this framework effectively so innovation reaches patients faster #HealthInnovation #PatientAccess #DataDrivenDecisions #EU #MS
Our goal is clear: a framework where medicines&devices are developed, clinically tested, manufactured and launched in Europe. This is how European patients can continue to access the best available therapies - and how we strengthen Europe’s health resilience. #HealthInnovation #EUHealth #PatientAccess #EU
Very good exchange organised by the European House @Ambrosetti_ in Florence 🇮🇹 It is undisputed: to keep our health systems sustainable, prevention cannot remain undervalued. We also agreed that innovation is reshaping diagnostics, treatment & care and 🇪🇺 must lead this process. https://t.co/JdTIENBj5Y #HealthInnovation #SustainableHealthcare #PreventiveHealth #IT #EU
In the latest episode of "The Sunday Daily," host Rachel Abrams discusses recent breakthroughs in longevity science and cellular rejuvenation with New York Times Magazine writer Susan Dominus, exploring the potential implications of this research for the $2 trillion global wellness market focused on anti-aging products and treatments. #Longevity #HealthInnovation #AgingResearch #Nocountrycodesarestronglyreferencedinthearticle.
In this episode of "The Sunday Daily," hosted by Rachel Abrams, the discussion focuses on recent breakthroughs in the science of longevity, particularly cellular rejuvenation, and features insights from New York Times Magazine writer Susan Dominus on the implications of this research and its funding within the growing $2 trillion global wellness market aimed at reversing the aging process. #Longevity #Aging #HealthInnovation #Therearenospecificcountrymentionsinthearticleprovided.Therefore #theresponseis:
Maria Patzwald, a 38-year-old mother, participated in a pioneering trial aimed at treating preeclampsia—which affects many pregnancies and poses serious risks—by targeting a specific protein in the blood, leading to a successful extension of her pregnancy by two weeks and improving the chances of survival for her premature son. #Pregnancy #HealthInnovation #PreEclampsia #US #DE #GB
GLP-1 weight loss injections have emerged as a groundbreaking solution to the obesity crisis, with around 100 million users globally, as clinical trials and patient testimonials reveal significant weight loss results, although access issues and the high costs of these medications raise concerns about equitable treatment options in the UK. #WeightLoss #ObesityTreatment #HealthInnovation #GB #US #DK
After struggling for years to conceive, Chrissy Walters was diagnosed with advanced cervical cancer shortly after the birth of her daughter, prompting discussions about mortality from a young age, while Australia moves towards potentially eliminating this cancer through vaccination and screening programs by 2035. #CervicalCancer #Vaccination #HealthInnovation #AU #SE #RW #GB #US #VU #PG
A nine-year-old boy named Ezra, who has spinal muscular atrophy (SMA), has seen his life transformed by treatments recently approved for routine use in the NHS, allowing him to reach milestones that were once thought unattainable after a grim prognosis. #SpinalMuscularAtrophy #RareDiseases #HealthInnovation #GB
A stronger Europe means being prepared for future health crises. The Global Health Resilience Initiative should boost innovation, secure critical supply chains and reinforce Europe’s leadership in research, prevention and strategic resilience. #GlobalHealth #HealthInnovation #EULeadership #EU
A new daily pill, orforglipron, may help individuals who stop using injectable weight-loss medications maintain their weight loss, as research indicates that patients using the pill were able to keep over 70% of the weight they lost, while those on a placebo maintained only 38-50%, with the study highlighting orforglipron's potential benefits in managing obesity as a chronic disease. #WeightLoss #ObesityTreatment #HealthInnovation #US #GB
A new daily pill called orforglipron may help individuals maintain their weight loss after discontinuing GLP-1 injections, with a study showing those who took the pill retained over 70% of their weight loss, while side effects were generally mild, and further research is needed to determine the long-term necessity of the treatment. #WeightLoss #ObesityTreatment #HealthInnovation #US #UK
Recent research suggests that a new daily pill called orforglipron may help individuals transitioning off weight-loss injections maintain their slimness, with trials showing that participants taking the pill retained over 70% of their weight loss compared to 38-50% in the placebo group, though further studies are needed to determine the long-term effectiveness and duration of treatment. #WeightLoss #ObesityTreatment #HealthInnovation #US #UK
Patients at Birmingham's Queen Elizabeth Hospital are among the first in the UK to receive CAR-T cell therapy, an innovative and costly treatment for B-cell acute lymphoblastic leukaemia, which re-engineers patients' own immune cells to target their cancer, offering hope for remission and better long-term outcomes. #CancerTreatment #CARtherapy #HealthInnovation #GB
